Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
8.61
+0.28 (3.36%)
Sep 26, 2025, 4:08 PM HKT

HKG:2563 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
3,1397,182----
Upgrade
Enterprise Value
2,5676,639----
Upgrade
Last Close Price
8.6119.70----
Upgrade
PS Ratio
53.5293.92----
Upgrade
PB Ratio
3.848.54----
Upgrade
P/TBV Ratio
3.908.54----
Upgrade
EV/Sales Ratio
43.7686.81----
Upgrade
Debt / Equity Ratio
0.000.000.000.000.00-
Upgrade
Asset Turnover
-0.090.080.040.07-
Upgrade
Inventory Turnover
-0.370.680.330.29-
Upgrade
Quick Ratio
8.697.4913.5314.8545.7675.10
Upgrade
Current Ratio
9.788.8314.4815.5647.7077.12
Upgrade
Return on Equity (ROE)
--18.99%-23.84%-17.72%-28.90%-9.98%
Upgrade
Return on Assets (ROA)
--12.47%-15.93%-12.84%-18.74%-7.04%
Upgrade
Return on Capital (ROIC)
--13.86%-16.98%-13.38%-19.07%-7.24%
Upgrade
Earnings Yield
-4.44%-2.13%----
Upgrade
FCF Yield
--2.13%----
Upgrade
Buyback Yield / Dilution
-1.98%-0.71%----
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.